Close

Amgen (AMGN), Celimmune Enter Licensing Agreement for AMG 714

March 2, 2015 10:10 AM EST Send to a Friend
Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that it has licensed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login